Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.

Kakeru HisakaneMasahiro SeikeTeppei SuganoAkiko YoshikawaKuniko MatsudaNatsuki TakanoSatoshi TakahashiRintaro NoroAkihiko Gemma

Published in: Thoracic cancer (2021)

Exosomal miR-210-3p may play a crucial role in resistance to osimertinib in the tumor microenvironment of EGFR-mutant NSCLC.

Keyphrases